Targeting CXCR2 enhances chemotherapeutic response, inhibits mammary tumor growth, angiogenesis, and lung metastasis.
about
CXC chemokines and chemokine receptors in gastric cancer: from basic findings towards therapeutic targetingChemokine receptor-specific antibodies in cancer immunotherapy: achievements and challengesInduction of CXCR2 ligands, stem cell-like phenotype, and metastasis in chemotherapy-resistant breast cancer cells.The role of chemoattractant receptors in shaping the tumor microenvironment.IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cellsThe Three A's in Asthma - Airway Smooth Muscle, Airway Remodeling & Angiogenesis.Correlation of C-X-C chemokine receptor 2 upregulation with poor prognosis and recurrence in human glioma.High throughput screening of cytokines, chemokines and matrix metalloproteinases in wound fluid induced by mammary surgery.Host Cxcr2-dependent regulation of mammary tumor growth and metastasisIL-8 signaling is involved in resistance of lung carcinoma cells to erlotinib.Blockade of CXCR2 signalling: a potential therapeutic target for preventing neutrophil-mediated inflammatory diseases.The chemokine receptors CXCR1 and CXCR2 regulate oral cancer cell behaviour.Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases.Strategic Endothelial Cell Tube Formation Assay: Comparing Extracellular Matrix and Growth Factor Reduced Extracellular Matrix.Epithelial-mesenchymal transition induced by GRO-α-CXCR2 promotes bladder cancer recurrence after intravesical chemotherapy.Inflammatory cytokine production in tumor cells upon chemotherapy drug exposure or upon selection for drug resistanceDifferential gene regulation and tumor inhibitory activities of alpha-, delta- and gamma-tocopherols in estrogen-mediated mammary carcinogenesis.A niche that triggers aggressiveness within BRCA1-IRIS overexpressing triple negative tumors is supported by reciprocal interactions with the microenvironment.CXCR2 is a novel cancer stem-like cell marker for triple-negative breast cancer
P2860
Q26849606-0DAD4324-5D0C-4E82-8C00-FF08E35BB46BQ26866236-552740C9-0494-4FF3-9E51-61AA28E0F7EBQ30353532-17C5A53B-2909-4E0B-858C-AD3732927902Q33993124-B3CCF956-5D24-4F63-8C4E-36D366A83E26Q35607293-790EF586-CC78-4143-877C-21FF0CAFD067Q35763560-ECA9D6CA-587F-4E3A-BA2E-9D370909884EQ36257047-20B5BCEE-853A-4E50-ABB3-283BEF0EDD88Q36557288-0863454D-02E8-46EB-81D9-76C43017F3A8Q36767227-7048B254-35B2-40EC-9FC2-77B755D92E51Q37520432-11EA538F-CF88-4E41-BA01-73526CBA9388Q38195671-D234B69E-541E-414A-B821-25EA31C13E20Q38981288-2F5A2589-F146-4F9A-AF64-5F05290288B0Q39321350-A8149EB5-9C05-4EFD-B59A-8E37D12D268BQ39431933-5486A23E-08E8-48CE-BBDC-55F069D9A4C5Q41233304-76FF6771-F48D-4E21-ABA5-E6FB298368B1Q41702685-B6EAFD98-5AB1-48DD-83F0-BA16A9B1C216Q42777954-12F9A901-986A-4DBB-9CA0-4288FBE00A89Q47275348-2393B458-1495-44AF-903F-FA19EAF4BB66Q58761517-864E5617-A893-4393-9A3C-E5EC6A2078C9
P2860
Targeting CXCR2 enhances chemotherapeutic response, inhibits mammary tumor growth, angiogenesis, and lung metastasis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Targeting CXCR2 enhances chemo ...... ogenesis, and lung metastasis.
@en
type
label
Targeting CXCR2 enhances chemo ...... ogenesis, and lung metastasis.
@en
prefLabel
Targeting CXCR2 enhances chemo ...... ogenesis, and lung metastasis.
@en
P2093
P2860
P1476
Targeting CXCR2 enhances chemo ...... iogenesis, and lung metastasis
@en
P2093
Dhananjay M Nawandar
Kalyan C Nannuru
Michelle L Varney
Rakesh K Singh
P2860
P304
P356
10.1158/1535-7163.MCT-12-0529
P577
2013-03-06T00:00:00Z